Meda Pharmaceuticals Overview
- Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
201
- Latest Deal Type
-
M&A
- (Cancelled)
- Financing Rounds
-
3
- Investments
-
1
Meda Pharmaceuticals General Information
Description
Manufacturer of pharmaceutical products in the United States. The company specializes in the manufacturing of pharmaceutical products for respiratory disease, allergy, gastroenterology, rheumatology and other pharmaceutical medicines.
Contact Information
Website
www.medapharma.us
Formerly Known As
Carter-Wallace (Healthcare Business)
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
- 265 Davidson Avenue
- Suite 300
- Franklin Township, NJ 08873
- United States
+1 (732) 000-0000
Meda Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Meda Pharmaceuticals Patents
Meda Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2677076-C | Compositions comprising carisoprodol and methods of use thereof | Active | 02-Mar-2007 | 0000000000 | |
| CA-2677076-A1 | Compositions comprising carisoprodol and methods of use thereof | Granted | 02-Mar-2007 | 0000000000 | |
| US-8895061-B2 | Compositions comprising carisoprodol and methods of use thereof | Active | 02-Mar-2007 | 0000000000 | 00 |
| US-20100189782-A1 | Compositions comprising carisoprodol and methods of use thereof | Granted | 02-Mar-2007 | 0000000000 | 00 |
| US-20070020330-A1 | Compositions comprising azelastine and methods of use thereof | Abandoned | 24-Nov-2004 | A61K9/0043 | 00 |
Meda Pharmaceuticals Executive Team (11)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Anthony Vaccarelli | Chief Information Officer & Vice President | ||
| Dennis Fuge | Vice President, Manufacturing | ||
| James Fitzpatrick | Vice President, Marketing |
Meda Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Meda Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Meda Pharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 01-May-2001 | 0000000000 | Laboratory Services (Healthcare) |
Meda Pharmaceuticals Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 0000000000 | 01-May-2001 | 000000000000000000 | Completed |
|